EMPA-RESPONSE
Randomized, double blind, placebo controlled, multicenter pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure
- Stage
- klaar
- Medicine
- empagliflozin
- Population
- Hartfalen
- Phase
- II
- First Patient In
- 1 December 2017
- Last Patient In
- -
- Last Patient Last Visit
- -